| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 7 |
| 1 | ACETAMINOPHEN 500MG | 7 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 7 |
| 3 | DIAZEPAM | 7 |
| 4 | DIAZEPAM ORAL | 7 |
| 5 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 7 |
| 6 | IBUPFROFEN | 7 |
| 7 | IBUPROFEN | 7 |
| 8 | IBUPROFEN 200 MG | 7 |
| 9 | IBUPROFEN 200MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 3 | 0.0024 |
| 1 | MEFENAMIC ACID | 1 | 0.0005 |
| 2 | FEBUXOSTAT TABLETS 40 MG | 2 | 0.0002 |
| 3 | INCLISIRAN | 1 | 0.0001 |
| 4 | FEBUXOSTAT | 2 | 0.0001 |
| 5 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| 6 | CEFTRIAXONE SODIUM | 4 | 0.0001 |
| 7 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 8 | DIAZEPAM ORAL | 7 | 0.0001 |
| 9 | DIAZEPAM | 7 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Benzodiazepine [EPC] | 7 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 2 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 1 | 0.0000 |
| 9 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |